Cargando…
Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder, characterized by proliferation of granulocytes, caused by a translocation that produces the Philadelphia chromosome resulting in constitutively active BCR-ABL tyrosine kinase. Imatinib and dasatinib are 2 BCR-ABL tyrosine kinase...
Autor principal: | Ryan, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113552/ https://www.ncbi.nlm.nih.gov/pubmed/30167550 http://dx.doi.org/10.1016/j.jacbts.2016.11.005 |
Ejemplares similares
-
High-Density Lipoprotein Nanoparticle Imaging in Atherosclerotic Vascular Disease
por: Leeper, Nicholas J., et al.
Publicado: (2017) -
CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016) -
Nitric Oxide Signaling in Heart Failure With Preserved Ejection Fraction
por: Cruz, Lucas, et al.
Publicado: (2017) -
The Role of Necroptosis in Atherosclerotic Disease
por: Leeper, Nicholas J.
Publicado: (2016) -
Genome-Wide Association Studies Candidate Gene to Dual Modifier of Nonalcoholic Steatohepatitis and Atherosclerosis
por: Miller, Clint L., et al.
Publicado: (2016)